Reprieve Cardiovascular has announced the first-in-human results of the Reprieve System at the CSI Focus D-HF—device therapies in heart failure—conference (13–14 December, Frankfurt, Germany). Results of the study demonstrated the potential of the Reprieve system to safely accelerate and maximise decongestion while reducing the likelihood of kidney injury for patients with ADHF. “Heart failure patients […] The post First-in-human results “demonstrate potential of Reprieve system” in ADHF treatment appeared first on Cardiovascular News .